Gadolinium3+-doped mesoporous silica nanoparticles as a potential magnetic resonance tracer for monitoring the migration of stem cells in vivo

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 119-127

  Shen, Yingying ^a,b   Shao, Yuanzhi ^c   He, Haoqiang ^a   Tan, Yunpu ^c   Tian, Xiumei ^b   Xie, Fukang ^b   Li, Li ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Gadolinium; Magnetic resonance imaging; Nanoparticles; Stem cells

Indexed keywords

GADOLINIUM MCM 41; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL LABELING; CELL MIGRATION; CELL PROLIFERATION; CELL TRACKING; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; IMMUNOFLUORESCENCE TEST; IN VIVO STUDY; MESENCHYMAL STEM CELL; MOUSE; NEURAL STEM CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT;

GADOLINIUM; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; STEM CELLS;

ANIMALS; BRAIN CHEMISTRY; CELL DIFFERENTIATION; CELL SURVIVAL; CELL TRACKING; GADOLINIUM; MAGNETIC RESONANCE IMAGING; MESENCHYMAL STROMAL CELLS; MUSCLES; NANOPARTICLES; RATS; RATS, SPRAGUE-DAWLEY; SILICON DIOXIDE;

MURINAE;

EID: 84872301555     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S38213     Document Type: Article

References (27)

1. Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells. 2007;25:2896-2902.
2. Kurozumi K, Nakamura K, Tamiya T, et al. Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther. 2004;11:96-104.
3. Wang JM, Zeng YS, Wu JL, Li Y, Teng YD. Cograft of neural stem cells and Schwann cells overexpressing TrkC and neurotrophin-3 respectively after rat spinal cord transection. Biomaterials. 2011;32:7454-7468.
4. Cao Q, Benton RL, Whittemore SR. Stem cell repair of central nervous system injury. J Neurosci Res. 2002;68:501-510.
5. Einstein O, Ben-Hur T. The changing face of neural stem cell therapy in neurologic diseases. Arch Neurol. 2008;65:452-456.
6. Park KI, Himes BT, Stieg PE, Tessler A, Fischer I, Snyder EY. Neural stem cells may be uniquely suited for combined gene therapy and cell replacement: evidence from engraftment of neurotrophin-3-expressing stem cells in hypoxic-ischemic brain injury. Exp Neurol. 2006;199: 179-190.
7. Sun C, Lee JSH, Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliver Rev. 2008;60:1252-1265.
8. Tseng CL, Shih IL, Stobinski L, Lin FH. Gadolinium hexanedione nanoparticles for stem cell labeling and tracking via magnetic resonance imaging. Biomaterials. 2010;31:5427-5435.
9. Yang H, Zhuang Y, Sun Y, et al. Targeted dual-contrast T1-and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles. Biomaterials. 2011;32:4584-4593.
10. Tran LA, Krishnamurthy R, Muthupillai R, et al. Gadonanotubes as magnetic nanolabels for stem cell detection. Biomaterials. 2010;31: 9482-9491.
11. Marquis BJ, Love SA, Braun KL, Haynes CL. Analytical methods to assess nanoparticle toxicity. Analyst. 2009;134:425-439.
12. Anderson SA, Lee KK, Frank JA. Gadolinium-fullerenol as a paramagnetic contrast agent for cellular imaging. Invest Radiol. 2006;41: 332-338.
13. Rogers WJ, Meyer CH, Kramer CM. Technology insight: in vivo cell tracking by use of MRI. Nat Clin Pract Cardiovasc Med. 2006;3: 554-562.
14. Modo M, Cash D, Mellodew K, et al. Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. Neuroimage. 2002;17:803-811.
15. Chen A, Siow B, Blamire AM, Lako M, Clowry GJ. Transplantation of magnetically labeled mesenchymal stem cells in a model of perinatal brain injury. Stem Cell Res. 2010;5:255-266.
16. Henning TD, Saborowski O, Golovko D, et al. Cell labeling with the positive MR contrast agent gadofluorine M. Eur Radiol. 2007;17: 1226-1234.
17. Lin YS, Hung Y, Su JK, et al. Gadolinium(III)-incorporated nanosized mesoporous silica as potential magnetic resonance imaging contrast agents. J Phys Chem B. 2004;108:15608-15611.
18. Li S, Liu H, Li L, et al. Mesoporous silica nanoparticles encapsulating Gd2O3 as a highly efficient magnetic resonance imaging contrast agent. Appl Phys Lett. 2011;98:093704.
19. Hahn MA, Singh AK, Sharma P, Brown SC, Moudgil BM. Nanoparticles as contrast agents for in-vivo bioimaging: current status and future perspectives. Anal Bioanal Chem. 2011;399:3-27.
20. Huang CC, Liu TY, Su CH, Lo YW, Chen JH, Yeh SC. Superparamagnetic hollow and paramagnetic porous Gd2O3 particles. Chem Mater. 2008;20:3840-3848.
21. Hsiao JK, Tsai CP, Chung TH, et al. Mesoporous silica nanoparticles as a delivery system of gadolinium for effective human stem cell tracking. Small. 2008;4:1445-1452.
22. 3+-incorporated mesoporous SiO2 nanoparticles for use as an efficient MRI contrast agent. Contrast Media Mol Imaging. 2010;6:110-118.
23. Miyawaki J, Yudasaka M, Imai H, et al. Synthesis of ultrafine Gd2O3 nanoparticles inside single-wall carbon nanohorns. J Phys Chem B. 2006;110:5179-5181.
24. Park JY, Baek MJ, Choi ES, et al. Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images. ACS Nano. 2009;3:3663-3669.
25. Shao YZ, Tian XM, Hu WY, et al. The properties of Gd2O3-assembled silica nanocomposite targeted nanoprobes and their application in MRI. Biomaterials. 2012;33:6438-6446.
26. Zhang W, Yan Q, Zeng YS, et al. Implantation of adult bone marrow-derived mesenchymal stem cells transfected with the neurotrophin-3 gene and pretreated with retinoic acid in completely transected spinal cord. Brain Res. 2010;1359:256-271.
27. Jandial R, Singec I, Ames CP, Snyder EY. Genetic modification of neural stem cells. Mol Ther. 2008;16:450-457.